This is pending peer review and then FDA approval for the device to launch under the company name Auricle Inc.
Unlike Jastreboff, Susan Shore is mainly liked and supported on TT.
Unlike Jastreboff, Susan Shore is mainly liked and supported on TT.
Recent reports suggests the device she has been working on may be the first in proper clinical trials to actually reduce the volume of tinnitus for some (particular emphasis on somatic tinnitus).